USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-28 обновлены отчеты компании TENX: 20232022
Tenax Therapeutics logo
Tenax Therapeutics TENX
$ 3.77 -1.82%

Tenax Therapeutics Мультипликаторы 2011-2024 | TENX

Мультипликаторы по годам Tenax Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

0.2 0.0 -0.6 1.7 -1.0 -0.3 -1.0 -1.2 -7.3 -2.2 -0.7 -3.1 -4.4

P/S

- - - - - - - - 2079.4 152.1 5.1 118.7 142.0

EPS

- - -1.6 -0.9 -1.4 -9.0 -6.3 -31.2 -0.5 -2.7 -6.3 -0.6 -0.5

EV (Enterprise Value)

-4.94 млн -90.2 тыс. 16.7 млн 10.9 млн 6.11 млн -8.97 млн 8.43 млн 51 млн 111 млн -3.87 млн 10.4 млн 51.9 млн 51.5 млн

EBITDA per Share

27.6 386 1.59 1.33 -1.36 -4.4 -6.52 -13.8 -9.71 -35.2 -58.1 -123 -170

EV/EBITDA

0.5 1.1 -0.4 1.5 -0.8 -2.3 -6.9 0.9 -1.8 -6.1 -5.0

PEG

0.0 0.0 0.01 0.01 -0.01 0.01 -0.01 0.0 -0.09 -0.04 -0.01 0.09 -0.26

P/B

0.2 0.1 4.8 3.7 2.2 0.2 1.0 3.2 1.5 0.5 -3.5 -142.4 -12.3

P/CF

-0.2 -0.0 -1.9 -1.8 -1.1 -0.3 -0.7 -3.5 -10.4 -4.7 -1.2 -5.8 -5.2

ROE %

95.22 740.11 -765.06 212.98 -222.51 -57.88 -99.53 -256.25 -19.99 -23.58 529.56 4540.56 280.53

ROA %

65.99 324.49 -541.94 143.42 -131.88 -51.09 -89.37 -188.19 -16.98 -20.92 -296.03 -379.35 -357.53

ROCE %

- 709.90 739.08 207.41 -223.21 -58.56 -103.65 -113.10 -17.58 -18.28 -388.73 -806.91 -1388.24

Current Ratio

3.3 1.8 3.4 3.2 2.4 8.5 8.0 2.2 3.9 22.9 1.0 0.8 0.7

DSO

- - - - - - - - 566.4 83.6 160.2 43.1 157.2

DIO

- - - - - - - - - - 839.9 593.7 428.6

DPO

- - - - - - - - - 1156.1 8273.2 3865.6 1481.1

Операционный цикл

- - - - - - - - - 83.6 1000.1 636.8 585.9

Финансовый цикл

- - - - - - - - - -1072.6 -7273.1 -3228.8 -895.2

Все данные представлены в валюте USD

Мультипликаторы поквартально Tenax Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

- - - - - - - - -0.15 -0.1 -1.64 - -0.18 -0.23 -0.38 - -0.33 -0.28 -0.33 - -1.05 -1.28 -0.84 - -0.87 -2.12 -2.33 - -0.15 -0.17 -0.19 -0.1 -0.1 -0.13 -0.11 -0.43 -0.14 -0.22 - -1.45 -1.23 -1.23 -2.06 -0.26 -0.97 -0.05 -0.12 -0.11 -0.12 -0.12 -0.12

EBITDA per Share

0.09 0.05 0.07 - 0.1 0.11 0.11 - 0.15 0.11 1.64 - 0.18 0.23 0.38 - 0.34 0.29 0.34 - 1.07 1.3 0.86 - 0.94 2.14 2.49 - 0.16 0.17 -0.2 -0.11 -0.11 -0.13 -0.11 -0.23 -0.14 -0.15 -0.09 -0.95 -0.41 -0.41 -0.74 -0.07 -0.32 -0.02 -0.05 0.12 -0.08 0.09 0.11

ROE %

73.02 129.31 95.50 -137.85 -85.37 -106.66 -181.20 -831.37 -879.38 -979.86 -909.55 -151.80 -92.86 14.09 107.19 148.51 161.56 115.67 84.84 39.05 52.94 53.79 71.55 84.40 109.33 120.37 113.82 20.73 15.98 -13.78 -46.69 -20.44 -26.75 -27.14 -26.28 -23.88 137.94 19.37 -288.15 -159.25 527.51 3334.83 3891.29 4801.45 4042.58 1437.69 1012.63 -179.48 78.64 -181.08 -77.04

ROA %

61.04 106.00 79.63 -45.51 -2.89 -21.80 -47.07 -537.61 -569.94 -644.89 -616.63 -102.23 -67.29 -0.03 58.90 88.02 99.54 76.12 62.45 34.46 46.94 47.90 64.09 75.79 94.10 99.93 89.62 15.22 11.29 -11.02 -35.73 -16.92 -22.86 -23.41 -23.01 -21.18 -90.61 -167.02 -222.55 -290.82 -335.43 -298.44 -268.83 -284.83 -225.33 -245.77 -167.97 81.22 -64.41 47.44 98.18

ROCE %

72.05 144.10 185.52 267.83 318.87 297.85 371.30 925.47 972.32 968.13 898.40 148.11 207.08 219.21 221.54 150.50 163.70 117.93 86.50 39.64 54.39 55.94 73.84 88.09 114.34 125.84 119.16 20.22 15.04 -16.36 -49.81 -21.68 -24.52 -24.72 -23.60 -21.36 86.10 17.32 -164.68 -72.36 43.22 1294.02 1588.08 1982.85 1822.97 701.42 467.48 -137.02 55.14 -126.96 -65.19

Current Ratio

19.7 17.1 15.4 1.8 6.0 5.3 1.8 3.4 5.3 2.0 3.1 3.1 3.1 3.1 3.1 2.5 2.5 2.5 2.5 8.5 8.5 8.5 8.5 9.8 9.8 9.8 9.8 3.8 3.8 3.8 3.8 5.8 5.8 5.8 5.8 9.3 7.7 9.3 8.9 0.7 2.9 1.2 0.6 0.9 1.0 0.9 0.9 - 0.6 0.8 0.4

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 97.5 - - - 16.1 132.3 443.9 127.9 11.3 3.6 3.3 2.2 13.0 17.1 80.1 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 97.5 - - - 16.1 132.3 443.9 127.9 11.3 3.6 3.3 2.2 13.0 17.1 80.1 -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 97.5 - - - 16.1 132.3 443.9 127.9 11.3 3.6 3.3 2.2 13.0 17.1 80.1 -

Все данные представлены в валюте USD